Literature DB >> 12441082

Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses.

M K Ghosh1, M V Borca, Polly Roy.   

Abstract

Particulate vector systems for the presentation of immunogenic epitopes provide an alternate and powerful approach for the delivery of immunogens of interest. In this article, we have exploited a viral protein of unknown function, bluetongue virus (BTV) nonstructural protein NS1, which forms distinct tubular aggregates in infected cells, as an immunogen delivery system. Tubules are helical assemblies of NS1 protein that present the C-terminus of the protein to the outer edge effectively displaying appended residues in a regular and repeating array akin to the coat of a filamentous phage. To assess the breadth of response induced following tubule-based immunization, two different immunodominant foreign peptides were inserted at the C-terminus of NS1 and chimeric tubules generated following expression in the baculovirus expression system. Both constructs, one carrying a peptide of foot and mouth disease virus (FMDV) (aa 135-144 of VP1) and the other, a peptide of influenza A virus (aa 186-205 of HA), effectively assembled into tubules and were easily purified. Subsequently, using in vitro assay systems, we demonstrated that each purified chimeric particle was capable of eliciting strong immune responses. Further, NS1-FMDV chimeric tubules could induce a potent immune response that could protect against disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441082     DOI: 10.1006/viro.2002.1648

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

Authors:  Natasha Larke; Aileen Murphy; Christoph Wirblich; Denise Teoh; Marie J Estcourt; Andrew J McMichael; Polly Roy; Tomás Hanke
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.

Authors:  Manisha Saini; Sudhanshu Vrati
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  Obesity vaccines.

Authors:  Mariana P Monteiro
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

4.  Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Authors:  Randall J Owens; Chang Limn; Polly Roy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Immunization against active ghrelin using virus-like particles for obesity treatment.

Authors:  Sara Andrade; Filipa Pinho; Andreia M Ribeiro; Marcos Carreira; Felipe F Casanueva; Polly Roy; Mariana P Monteiro
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.

Authors:  Vesna Blazevic; Maria Malm; Daisuke Arinobu; Suvi Lappalainen; Timo Vesikari
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 7.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

Review 8.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14

9.  Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.

Authors:  Francesca Bugli; Valeria Caprettini; Margherita Cacaci; Cecilia Martini; Francesco Paroni Sterbini; Riccardo Torelli; Stefano Della Longa; Massimiliano Papi; Valentina Palmieri; Bruno Giardina; Brunella Posteraro; Maurizio Sanguinetti; Alessandro Arcovito
Journal:  Int J Nanomedicine       Date:  2014-05-30

Review 10.  Virus-like particles as a vaccine delivery system: myths and facts.

Authors:  Polly Roy; Rob Noad
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.